Ignite Creation Date:
2025-12-24 @ 3:48 PM
Ignite Modification Date:
2025-12-26 @ 11:23 AM
Study NCT ID:
NCT05500092
Status:
RECRUITING
Last Update Posted:
2024-02-15
First Post:
2022-07-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
An Open Label, Randomized Study of Neoadjuvant Nivolumab and Chemotherapy, With or Without Sub-ablative Stereotactic Body Radiation Therapy, for Resectable Stage IIA to IIIB Non-small Cell Lung Cancer
Sponsor:
Montefiore Medical Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-01-25
Start Date Type:
ACTUAL
Primary Completion Date:
2025-07
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-07
Completion Date Type:
ESTIMATED
First Submit Date:
2022-07-15
First Submit QC Date:
None
Study First Post Date:
2022-08-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-02-13
Last Update Post Date:
2024-02-15
Last Update Post Date Type:
ACTUAL